Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some ...

A variety of GLP-1 drugs that were developed to treat Type 2 diabetes, including Novo Nordisk’s Ozempic, have secured label ...

GLP‑1 receptor agonists are widely recognized for aiding weight loss and controlling blood sugar, but access remains limited — especially for Medicare and Medicaid patients. That might change with a ...

Rechelle never thought her body would let her down. She was 35, living in London with a dream job. She was even making plans ...

Despite this, one in five young adults who meet the criteria for the drugs are uninsured and one-third denied having a routine place for healthcare.

The Maryland Prescription Drug Affordability Board (PDAB) found that Eli Lilly and Boehringer Ingelheim’s Jardiance (empagliflozin) and AstraZeneca’s Farxiga (dapagliflozin) present affordability ...

A hormone expert has revealed a bizarre side-effect that could be triggered by weight loss jabs: users' sex drive may go ...

Over the course of his storied music career, rock icon Ozzy Osbourne faced health battles with substance abuse and Parkinson's disease.

Legislative efforts and a Trump administration initiative could lead in the near future to Medicare beneficiary access to ...